We are live on ! Find out more
NCM

NovaQuest Capital Management Portfolio holdings

AUM $54.3M
1-Year Est. Return 163.39%
This Fund
S&P 500
This Quarter Est. Return
-40.61%
1 Year Est. Return
+163.39%
3 Year Est. Return
+45.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$35.1M
AUM Growth
-$44.1M
Cap. Flow
-$19.8M
Cap. Flow %
-56.54%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$19.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYOV
1
DELISTED
Myovant Sciences Ltd.
MYOV
$26.2M 74.74%
3,474,645
– –
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$8.87M 25.26%
598,985
-959,441
-62% -$19.8M

Similar funds

SCM
Stumpf Capital Management Scottsdale, Arizona $53.8M AUM 43.02% 1-Year Est. Return
RMCP
Red Mountain Capital Partners Los Angeles, California $55.4M AUM 35.53% 1-Year Est. Return
OQC
Optimum Quantvest Corp Stamford, Connecticut $51.8M AUM 10.08% 1-Year Est. Return
FTIM
Flowering Tree Investment Management Singapore $57.2M AUM 50.6% 1-Year Est. Return
OAM
Orinda Asset Management Lafayette, California $48.7M AUM 26.85% 1-Year Est. Return
FVP
Firefly Value Partners Newtown, Pennsylvania $59.9M AUM 5.97% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
SBA
Secrest Blakey & Associates Raleigh, North Carolina $43.7M AUM 1.11% 1-Year Est. Return

NovaQuest Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, NovaQuest Capital Management held 2 positions worth $35.1M, down 56% from $79.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

NovaQuest Capital Management withdrew a net $19.8M in Q1 2020, reducing 1 holding. Its largest reduction was Revance Therapeutics, Inc., cutting an estimated $19.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • NovaQuest Capital Management's biggest Q1 2020 reduction was Revance Therapeutics, Inc., cutting an estimated $19.8M.
  • NovaQuest Capital Management's ten largest holdings make up 100% of its $35.1M portfolio in Q1 2020.
  • NovaQuest Capital Management opened 0 new positions and closed 0 in Q1 2020.
  • NovaQuest Capital Management's portfolio value fell 56% quarter-over-quarter to $35.1M.

Based on NovaQuest Capital Management's 13F filing for Q1 2020, filed 24 Apr 2020.